Foldax closes US$20 million financing

Foldax has announced the closing of a $20 million Series D round of funding. According to a press release, MemorialCare Innovation Fund (MCIF) led the round, with Angel Physicians Fund (APF) and Sayan Bioventures joining as new investors. All existing investors also participated in the round, including BioStar Capital, Kairos Ventures and Caltech. Brant [...]

2020-06-23T11:23:10+00:00June 23rd, 2020|Tags: , , , , |

Foldax completes first-in-human use of next-generation “Tria polymer” heart valve for aortic valve disease

Tria heart valve Foldax announced its first-in-human use of the Tria heart valve under its FDA early feasibility study for the treatment of aortic valve disease. Clinicians at Beaumont Hospital, Royal Oak, in Michigan, implanted this innovative flexible polymer heart valve, which has been designed to address durability and thrombogenicity issues of [...]

2019-09-20T15:50:57+00:00September 20th, 2019|Tags: , |
Go to Top